NDC 49873-109

Stonarhini

Chlorpheniramine Maleate, Phenylephrine

Stonarhini is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Sato Pharmaceutical Co., Ltd.. The primary component is Chlorpheniramine Maleate; Phenylephrine Hydrochloride.

• Product ID: 49873-109_630430bf-675f-4165-abf9-17abcd738464
• NDC: 49873-109
• Product Type: Human Otc Drug
• Proprietary Name: Stonarhini
• Generic Name: Chlorpheniramine Maleate, Phenylephrine
• Dosage Form: Tablet
• Route of Administration: ORAL
• Marketing Start Date: 2001-11-16
• Marketing Category: OTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL
• Application Number: part341
• Labeler Name: Sato Pharmaceutical Co., Ltd.
• Substance Name: CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE
• Active Ingredient Strength: 2 mg/1; mg/1
• NDC Exclude Flag: N
• Listing Certified Through: 2019-12-31

Packaging

NDC 49873-109-01

4 BLISTER PACK in 1 CARTON (49873-109-01) > 6 TABLET in 1 BLISTER PACK

• Marketing Start Date: 2001-11-16
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 49873-109-01 [49873010901]

Stonarhini TABLET

• Marketing Category: OTC monograph final
• Application Number: part341
• Product Type: HUMAN OTC DRUG
• Marketing Start Date: 2001-11-16

Drug Details

Active Ingredients

Ingredient	Strength
CHLORPHENIRAMINE MALEATE	2 mg/1

OpenFDA Data

• SPL SET ID: cc353280-0b4c-418c-93fe-850125955009
• Manufacturer:
  • Sato Pharmaceutical Co., Ltd.
• UNII:
  • V1Q0O9OJ9Z
  • 04JA59TNSJ
• RxNorm Concept Unique ID - RxCUI:
  • 1242246
  • 1242240
• UPC Code:
  • 0349873033037